Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aurase Wound Gel for Venous Leg Ulcers
NCT04956900Phase 2Completed
- Sponsor
- SolasCure
- Start
- Aug 2021
- Primary completion
- Feb 2023
- Modality
- Therapeutic Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of aurase in venous leg ulcer (VLU), sponsored by SolasCure. Started Aug 2021; status: completed.
02
Drugs
aurase
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT04956900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04956900.